2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation
US$ 8,640.00
About this Report This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ... ; Reviews features and operating characteristics of major analyzers used for STD testing; Profiles key suppliers and potential market entrants developing ...
January 2017
350 pages
2017 Emerging Nucleic Acid Testing (NAT)Technologies and Strategic Profiles of Leading Suppliers
US$ 3,465.00
This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing ... other. The report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics ...
January 2017
180 pages
2017 Infectious Disease Market: Leading Suppliers Strategic Profiles
US$ 3,150.00
... technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, ... others. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies ...
January 2017
155 pages
2017-2021 Infectious Disease Market: Country Volume and Sales Forecasts
US$ 2,205.00
This report provides a worldwide overview of the infectious disease testing market environment, structure, size and growth. Includes estimates of the number of laboratories performing infectious disease tests, as well as ten-year test volume and sales forecasts by country. Contains 15 pages and 3 tables
January 2017
15 pages
2017-2021 Transfusion Diagnostics Market: US, Europe, Japan--Strategic Profiles of Leading Blood Bank Reagent and Instrument Suppliers, Country Volume and Sales Forecasts
US$ 3,465.00
This report provides a worldwide overview of the Transfusion Diagnostic Testing market, including estimates of facilities performing blood banking tests, as well as test ... of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative ...
January 2017
60 pages
2017-2021 Tumor Marker Testing Market: US, Europe, Japan--Strategic Profiles of Leading Cancer Diagnostic Reagent and Instrument Suppliers, Country Volume and Sales Forecasts
US$ 3,465.00
... report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report ... emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, ...
January 2017
104 pages
2017-2021 HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
US$ 2,070.00
... the AIDS diagnostics market in Germany. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV, NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: Hospitals Commercial/Private Laboratories Blood ...
January 2017
250 pages
2017 Hong Kong Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies
US$ 3,105.00
... the next five years. Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd ... over 40 blood typing, grouping and infectious disease screening tests, including NAT. Current and Emerging Products Analysis of current and emerging blood typing, grouping ...
January 2017
400 pages
2017 New Zealand Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies
US$ 3,105.00
... , marketing tactics, and new products in R&D. Market Segmentation Analysis Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease ... OpenArray, MALDI-TOF-MS, Mini-Sequencing Strategic Recommendations New product development opportunities for blood typing, grouping and infectious disease NAT assays and ...
January 2017
400 pages
2017 Saudi Arabia Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies
US$ 3,105.00
... the next five years. Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd ... over 40 blood typing, grouping and infectious disease screening tests, including NAT. Current and Emerging Products Analysis of current and emerging blood typing, grouping ...
January 2017
400 pages
2017 South Korea Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies
US$ 3,105.00
... the next five years. Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd ... over 40 blood typing, grouping and infectious disease screening tests, including NAT. Current and Emerging Products Analysis of current and emerging blood typing, grouping ...
January 2017
400 pages
2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies
US$ 51,750.00
... market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis Comprehensive market segmentation analysis, including review of the market ... disease NAT assays and instrumentation with significant market appeal. Alternative market penetration strategies. Potential market entry barriers and risks. Contains 1,225 ...
January 2017
1225 pages
2017-2021 Europe Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
US$ 17,730.00
... (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country ... 200 current and emerging cancer diagnostic tests, including: Biochemical Markers Oncogenes Growth Factors Hormones Colony Stimulating Factors Lymphokines Immunohistochemical ...
January 2017
820 pages
